New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?

BACKGROUND: After an acute coronary syndrome, dual antiplatelet therapy with clopidogrel plus aspirin is still a standard of care, but several new approaches have been investigated. OBJECTIVES: The present study re-examined the studies published thus far on this topic to evaluate the effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Messori, Andrea, Fadda, Valeria, Gatto, Roberta, Maratea, Dario, Trippoli, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Safnek 2014
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109037/
https://www.ncbi.nlm.nih.gov/pubmed/25177676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109037/
https://www.ncbi.nlm.nih.gov/pubmed/25177676

Ejemplares similares